/C O R R E C T I O N -- Menarini I.F.R./

In the news release, Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of "Fondazione Internazionale Menarini", issued 24-Oct-2019 by Menarini I.F.R. over PR Newswire, we are advised by the company that the second paragraph, 5th sentence, should read "Nitric Oxide Society" rather than "Nitric Acid Society" as originally issued inadvertently. The complete, corrected release follows:

Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of "Fondazione Internazionale Menarini"

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ -- His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world's most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission of the "Fondazione Internazionale Menarini" which welcomes the winner of the Nobel prize for Medicine, Louis Ignarro.

https://mma.prnewswire.com/media/1017026/Louis_Ignarro.jpg [https://mma.prnewswire.com/media/1017026/Louis_Ignarro.jpg]

Born in Brooklyn (New York), the son of Italian immigrants, Ignarro discovered his love for chemistry at the age of 8 when he carried out his first experiments with a children's game. This passion never faded and, after a brilliant academic career at the Columbia University in New York and long periods of research in other prestigious American universities, he joined the University of California, Los Angeles (UCLA). It was during this time that he was awarded the Nobel Prize for Medicine and Physiology "for his contribution in discovering the workings of the nitric acid molecule in the cardiovascular system." It is to his studies that we owe the development of medicines commonly used in treating erectile dysfunction and hypertension. Ignarro is one of the founders of the Nitric Oxide Society and is currently Professor of Pharmacology in the Department of Molecular Medical Pharmacology at the UCLA School of Medicine.

Speaking from Los Angeles, Louis Ignarro, had this to say about this exciting collaboration with the Foundation: "Having taught in several American universities, I have always appreciated the work carried out by the Fondazione Internazionale Menarini: their educational activities at congresses and on the internet represent a unique scientific asset. Thanks to this collaboration, I shall continue to contribute to the scientific instruction of researchers, clinicians, students, and young people."

"We are honoured to have Professor Ignarro join our Scientific Committee," commented Lorenzo Melani, Chairman and Scientific Director of the Fondazione Internazionale Menarini. "With the help of his experience, we shall continue to further promote research and understanding in the fields of biology, pharmacology, medicine, economics, and human sciences, which represent the institutional aims of the Fondazione Internazionale Menarini."

For further information on "Fondazione Internazionale Menarini" visit the website https://www.en.fondazione-menarini.it/ [https://www.en.fondazione-menarini.it/].

Photo - https://mma.prnewswire.com/media/1017026/Louis_Ignarro.jpg [https://mma.prnewswire.com/media/1017026/Louis_Ignarro.jpg] Logo - https://mma.prnewswire.com/media/1017025/Menarini_Logo.jpg [https://mma.prnewswire.com/media/1017025/Menarini_Logo.jpg]

https://mma.prnewswire.com/media/1017025/Menarini_Logo.jpg [https://mma.prnewswire.com/media/1017025/Menarini_Logo.jpg]

CONTACT: Valeria Speroni Cardi, Lorenza Sbroma Tomaro, Menarini Press Office, Via dei Sette Santi 3, +39-055-56801, ufficiostampa@menarini.it

Web site: https://www.menarini.it/

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234